Editions Ecce Terra CAMPARIS electron GFP microprobe facility Microscopie Confocale

Laboratoire de Microsondes Chromogenic in situ hybridization (CISH) – Microscope Electronique à Balayage

fallback-image

Ruxolitinib Invivogen

Human Anti centriole and centrosome antibody IgG ELISA kit

E01A0698-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Anti centriole and centrosome antibody IgG in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human IgG antibody Laboratories manufactures the ruxolitinib invivogen reagents distributed by Genprice. The Ruxolitinib Invivogen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Ruxolitinib products are available in stock. Specificity: Ruxolitinib Category: Invivogen

True north Cryobox 15mLBlue

PK10
EUR 212.4

True north Cryobox 50mLNatural

PK10
EUR 210

True north Cryobox 50mLBlue

PK10
EUR 210

True north Cryobox1.5/2mLNatural

PK10
EUR 162

True north Cryobox1.5/2.0mLGreen

PK10
EUR 162

Human true insulin,TI ELISA Kit

96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human true insulin,TI ELISA Kit

96T
EUR 567.6

Chemicals information

Ruxolitinib (free base)

GW2265-25 25
EUR 216.3

Ruxolitinib (free base)

GW2265-5 5
EUR 116.1

Ruxolitinib (S enantiomer)

HY-50856A 5mg
EUR 408

Ruxolitinib . phosphate salt

10-043 25 mg
EUR 387.96
Description: Water-soluble phosphate salt of Ruxolitinib. Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19)

Ruxolitinib . phosphate salt

GW4048-100 100
EUR 322.4

Ruxolitinib . phosphate salt

GW4048-25 25
EUR 157.3

Ruxolitinib . phosphate salt

GW4048-5 5
EUR 92.4

Ruxolitinib (JAK kinase inhibitor)

SIH-509-25MG 25 mg
EUR 750
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml).

Ruxolitinib (JAK kinase inhibitor)

SIH-509-5MG 5 mg
EUR 285.6
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml).

GFP-lacZ (His) Lentiviral particles, invivo ready

LVP021-PBS 5x107 IFU/ml x 200ul
EUR 1034.4
Description: Pre-made lentiviral particles expressing GFP-LacZ fusion gene with C-term His tag. A RFP was bicistronically expressed under the same suCMV promoter. Concentrated Particles are provided in PBS solution.

S-Ruxolitinib (INCB018424)

A4149-1 1 mg
EUR 277.2
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

S-Ruxolitinib (INCB018424)

A4149-5 5 mg
EUR 514.8
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

S-Ruxolitinib (INCB018424)

A4149-5.1 10 mM (in 1mL DMSO)
EUR 367.2
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-10ug

QP9985-iv-10ug 10ug
EUR 936

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-50ug

QP9985-iv-50ug 50ug
EUR 554.4

ODN 2041-Non-CpG ODN. Invitro control for rabbit cells. Antigen grade

ODN2041-1 1 mg
EUR 781.2

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-100ug

QP9985-iv-100ug 100ug
EUR 1424.4

Articles récents

septembre 2023
L M M J V S D
 123
45678910
11121314151617
18192021222324
252627282930  

Catégories

Étiquettes